25 XP   0   0   10

Pulmonx Corp
Buy, Hold or Sell?

Let's analyse Pulmonx together

PenkeI guess you are interested in Pulmonx Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pulmonx Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pulmonx Corp

I send you an email if I find something interesting about Pulmonx Corp.

Quick analysis of Pulmonx (30 sec.)










What can you expect buying and holding a share of Pulmonx? (30 sec.)

How much money do you get?

How much money do you get?
$0.52
When do you have the money?
1 year
How often do you get paid?
4.2%

What is your share worth?

Current worth
$3.07
Expected worth in 1 year
$2.14
How sure are you?
20.8%

+ What do you gain per year?

Total Gains per Share
$-0.41
Return On Investment
-5.4%

For what price can you sell your share?

Current Price per Share
$7.50
Expected price per share
$6.55 - $9.71
How sure are you?
50%

1. Valuation of Pulmonx (5 min.)




Live pricePrice per Share (EOD)

$7.50

Intrinsic Value Per Share

$-9.29 - $-10.70

Total Value Per Share

$-6.22 - $-7.63

2. Growth of Pulmonx (5 min.)




Is Pulmonx growing?

Current yearPrevious yearGrowGrow %
How rich?$118.3m$167.9m-$37.4m-28.7%

How much money is Pulmonx making?

Current yearPrevious yearGrowGrow %
Making money-$15.2m-$14.6m-$575.7k-3.8%
Net Profit Margin-89.9%-111.6%--

How much money comes from the company's main activities?

3. Financial Health of Pulmonx (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#135 / 339

Most Revenue
#161 / 339

Most Profit
#285 / 339

Most Efficient
#240 / 339

What can you expect buying and holding a share of Pulmonx? (5 min.)

Welcome investor! Pulmonx's management wants to use your money to grow the business. In return you get a share of Pulmonx.

What can you expect buying and holding a share of Pulmonx?

First you should know what it really means to hold a share of Pulmonx. And how you can make/lose money.

Speculation

The Price per Share of Pulmonx is $7.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pulmonx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pulmonx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.07. Based on the TTM, the Book Value Change Per Share is $-0.23 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pulmonx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.36-4.8%-0.39-5.3%-0.38-5.1%-0.30-3.9%-0.24-3.2%
Usd Book Value Change Per Share-0.19-2.6%-0.23-3.1%-0.25-3.4%0.162.2%0.131.7%
Usd Dividend Per Share0.000.0%0.131.7%0.000.0%0.030.4%0.020.3%
Usd Total Gains Per Share-0.19-2.6%-0.10-1.4%-0.25-3.4%0.192.5%0.152.0%
Usd Price Per Share12.75-11.84-16.16-17.84-14.12-
Price to Earnings Ratio-8.84--7.53--10.45--14.32--11.34-
Price-to-Total Gains Ratio-66.15--30.46--62.80--86.96--86.96-
Price to Book Ratio4.15-3.52-3.65-3.68-2.91-
Price-to-Total Gains Ratio-66.15--30.46--62.80--86.96--86.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.5
Number of shares133
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.03
Usd Book Value Change Per Share-0.230.16
Usd Total Gains Per Share-0.100.19
Gains per Quarter (133 shares)-13.5425.14
Gains per Year (133 shares)-54.16100.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
169-123-64158691
2138-246-11829172192
3207-370-17244258293
4276-493-22658344394
5345-616-28073430495
6414-739-33487516596
7483-862-388102602697
8552-985-442116688798
9621-1109-496131774899
10690-1232-5501458601000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.019.00.00.0%0.024.00.00.0%0.024.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%2.014.03.010.5%4.017.03.016.7%4.017.03.016.7%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.018.05.3%1.00.023.04.2%1.00.023.04.2%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.013.03.015.8%5.016.03.020.8%5.016.03.020.8%

Fundamentals of Pulmonx

About Pulmonx Corp

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-04-11 13:52:29.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pulmonx Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pulmonx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • A Net Profit Margin of -72.0% means that $-0.72 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pulmonx Corp:

  • The MRQ is -72.0%. The company is making a huge loss. -2
  • The TTM is -89.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-72.0%TTM-89.9%+17.9%
TTM-89.9%YOY-111.6%+21.7%
TTM-89.9%5Y-96.9%+7.0%
5Y-96.9%10Y-403.1%+306.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.0%-11.2%-60.8%
TTM-89.9%-19.6%-70.3%
YOY-111.6%-14.4%-97.2%
5Y-96.9%-21.3%-75.6%
10Y-403.1%-24.8%-378.3%
1.1.2. Return on Assets

Shows how efficient Pulmonx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • -7.8% Return on Assets means that Pulmonx generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pulmonx Corp:

  • The MRQ is -7.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-8.0%+0.3%
TTM-8.0%YOY-7.0%-1.0%
TTM-8.0%5Y-22.3%+14.3%
5Y-22.3%10Y-33.1%+10.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%-4.0%-3.8%
TTM-8.0%-4.5%-3.5%
YOY-7.0%-4.8%-2.2%
5Y-22.3%-4.0%-18.3%
10Y-33.1%-5.2%-27.9%
1.1.3. Return on Equity

Shows how efficient Pulmonx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • -11.7% Return on Equity means Pulmonx generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pulmonx Corp:

  • The MRQ is -11.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.7%TTM-11.7%-0.1%
TTM-11.7%YOY-8.7%-2.9%
TTM-11.7%5Y-56.9%+45.2%
5Y-56.9%10Y-61.7%+4.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.7%-3.9%-7.8%
TTM-11.7%-5.6%-6.1%
YOY-8.7%-5.9%-2.8%
5Y-56.9%-6.1%-50.8%
10Y-61.7%-7.1%-54.6%

1.2. Operating Efficiency of Pulmonx Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pulmonx is operating .

  • Measures how much profit Pulmonx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • An Operating Margin of -72.2% means the company generated $-0.72  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pulmonx Corp:

  • The MRQ is -72.2%. The company is operating very inefficient. -2
  • The TTM is -91.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-72.2%TTM-91.6%+19.4%
TTM-91.6%YOY-111.6%+20.0%
TTM-91.6%5Y-93.9%+2.2%
5Y-93.9%10Y-371.5%+277.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.2%-22.8%-49.4%
TTM-91.6%-17.1%-74.5%
YOY-111.6%-13.4%-98.2%
5Y-93.9%-19.2%-74.7%
10Y-371.5%-24.0%-347.5%
1.2.2. Operating Ratio

Measures how efficient Pulmonx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are $1.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pulmonx Corp:

  • The MRQ is 1.722. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.916. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.722TTM1.916-0.194
TTM1.916YOY2.116-0.200
TTM1.9165Y1.904+0.012
5Y1.90410Y4.521-2.617
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7221.428+0.294
TTM1.9161.426+0.490
YOY2.1161.503+0.613
5Y1.9041.440+0.464
10Y4.5211.371+3.150

1.3. Liquidity of Pulmonx Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pulmonx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 6.49 means the company has $6.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pulmonx Corp:

  • The MRQ is 6.491. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.181. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.491TTM8.181-1.689
TTM8.181YOY9.638-1.457
TTM8.1815Y8.303-0.123
5Y8.30310Y7.766+0.537
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4912.787+3.704
TTM8.1812.763+5.418
YOY9.6383.488+6.150
5Y8.3033.617+4.686
10Y7.7663.514+4.252
1.3.2. Quick Ratio

Measures if Pulmonx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • A Quick Ratio of 7.10 means the company can pay off $7.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pulmonx Corp:

  • The MRQ is 7.096. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.835. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.096TTM8.835-1.739
TTM8.835YOY10.601-1.767
TTM8.8355Y8.485+0.350
5Y8.48510Y6.717+1.768
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0961.539+5.557
TTM8.8351.660+7.175
YOY10.6012.139+8.462
5Y8.4852.300+6.185
10Y6.7172.255+4.462

1.4. Solvency of Pulmonx Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pulmonx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pulmonx to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.34 means that Pulmonx assets are financed with 33.9% credit (debt) and the remaining percentage (100% - 33.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pulmonx Corp:

  • The MRQ is 0.339. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.313. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.313+0.026
TTM0.313YOY0.192+0.120
TTM0.3135Y0.963-0.650
5Y0.96310Y1.125-0.162
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3390.389-0.050
TTM0.3130.386-0.073
YOY0.1920.338-0.146
5Y0.9630.442+0.521
10Y1.1250.460+0.665
1.4.2. Debt to Equity Ratio

Measures if Pulmonx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pulmonx to the Medical Devices industry mean.
  • A Debt to Equity ratio of 51.2% means that company has $0.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pulmonx Corp:

  • The MRQ is 0.512. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.456. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.456+0.057
TTM0.456YOY0.238+0.218
TTM0.4565Y10.714-10.258
5Y10.71410Y8.731+1.983
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5120.559-0.047
TTM0.4560.560-0.104
YOY0.2380.478-0.240
5Y10.7140.624+10.090
10Y8.7310.674+8.057

2. Market Valuation of Pulmonx Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pulmonx generates.

  • Above 15 is considered overpriced but always compare Pulmonx to the Medical Devices industry mean.
  • A PE ratio of -8.84 means the investor is paying $-8.84 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pulmonx Corp:

  • The EOD is -5.203. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.845. Based on the earnings, the company is expensive. -2
  • The TTM is -7.529. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.203MRQ-8.845+3.642
MRQ-8.845TTM-7.529-1.316
TTM-7.529YOY-10.450+2.921
TTM-7.5295Y-14.325+6.796
5Y-14.32510Y-11.341-2.984
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.203-1.037-4.166
MRQ-8.845-1.578-7.267
TTM-7.529-2.041-5.488
YOY-10.450-2.971-7.479
5Y-14.325-2.058-12.267
10Y-11.341-1.463-9.878
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pulmonx Corp:

  • The EOD is -8.354. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.203. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.373. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.354MRQ-14.203+5.848
MRQ-14.203TTM-12.373-1.829
TTM-12.373YOY-13.121+0.748
TTM-12.3735Y-16.990+4.616
5Y-16.99010Y-13.450-3.539
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-8.354-1.007-7.347
MRQ-14.203-1.544-12.659
TTM-12.373-3.018-9.355
YOY-13.121-6.339-6.782
5Y-16.990-4.928-12.062
10Y-13.450-4.950-8.500
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pulmonx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.15 means the investor is paying $4.15 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pulmonx Corp:

  • The EOD is 2.443. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.153. Based on the equity, the company is fair priced.
  • The TTM is 3.521. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.443MRQ4.153-1.710
MRQ4.153TTM3.521+0.632
TTM3.521YOY3.645-0.124
TTM3.5215Y3.679-0.158
5Y3.67910Y2.912+0.766
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.4431.987+0.456
MRQ4.1532.379+1.774
TTM3.5212.444+1.077
YOY3.6453.215+0.430
5Y3.6793.833-0.154
10Y2.9124.163-1.251
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pulmonx Corp.

3.1. Institutions holding Pulmonx Corp

Institutions are holding 93.532% of the shares of Pulmonx Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31PRIMECAP Management Company14.65190.05756464511240502.2463
2023-12-31FMR Inc8.58780.00323309501127966663.0429
2023-12-31BlackRock Inc8.08840.00131170631814036.1793
2023-09-30Point72 Asset Management, L.P.7.60280.08832929903-396162-11.9108
2023-12-31Morgan Stanley - Brokerage Accounts5.9130.00262278721588952.6531
2023-12-31Vanguard Group Inc5.36220.00062066442426062.1052
2023-12-31Divisadero Street Capital Management, LP3.6514.0535140699314069930
2023-09-30Deerfield Management Co2.64150.23171017958-46327-4.3529
2023-09-30KPCB XIII Associates LLC2.58185.534899497100
2023-09-30BRAIDWELL LP2.56520.3227988559-10803-1.081
2023-12-31BNP Paribas Investment Partners SA2.41220.033929588320633.5724
2023-12-31State Street Corporation2.27040.0005874965145421.6901
2023-12-31Victory Capital Management Inc.2.21560.0115853846-96917-10.1936
2023-12-31Geode Capital Management, LLC2.09280.0011806505421385.5128
2023-12-31Millennium Management LLC2.08630.0044804023427390113.4765
2023-12-31Franklin Resources Inc1.92650.0044742412-1461-0.1964
2023-09-30D. E. Shaw & Co LP1.73430.0072668358-48020-6.7032
2023-12-31Rock Springs Capital Management LP1.69290.204865240000
2023-12-31Deutsche Bank AG1.36140.00345246604777921019.4418
2023-09-30Jacobs Levy Equity Management, Inc.1.31140.0309505379-175166-25.7391
Total 80.749410.596631118698+3312682+10.6%

3.2. Funds holding Pulmonx Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31PRIMECAP Odyssey Aggressive Growth9.8320.67223788981670101.8004
2024-01-31Fidelity Small Cap Growth3.53450.31561362111-1644-0.1205
2024-02-29Vanguard Total Stock Mkt Idx Inv2.66840.0006102834400
2024-03-28iShares Russell 2000 ETF2.34470.01289036004350.0482
2023-12-31Vanguard US Opportunities Ins USD Acc1.96840.771475857098401.3142
2024-01-31Fidelity Advisor Small Cap I1.69580.461165350000
2023-12-31Franklin US Small Cap Growth Equity1.67890.297664701600
2024-02-29Franklin Small Cap Growth Adv1.67890.205764701600
2024-02-29BNP Paribas Health Cr Innovtr Cl Cap1.67220.3436444324450.0691
2024-02-29Fidelity Select Pharmaceuticals Port1.5940.5261614300325600112.7814
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.49390.0052575726-695-0.1206
2024-02-29Strategic Advisers Fidelity US TtlStk1.30730.004450380021740075.9078
2024-01-31Fidelity Small Cap Growth K61.28360.307549466816440.3335
2024-01-31Fidelity Small Cap Index0.96080.019837027636801.0038
2024-02-29BNP Paribas US Small Cap Classic R0.87830.3493338468154564.785
2024-02-29BlackRock Health Sciences Term Trust0.87080.158633556600
2024-03-31Bridge Builder Small/Mid Cap Growth0.85030.035432767600
2024-03-28iShares Russell 2000 Growth ETF0.8290.0254319478-371-0.116
2023-12-31Victory RS Small Cap Growth CIT N0.78260.6955301610-50490-14.3397
2023-12-31Victory RS Small Cap Growth A0.78260.6957301610-50490-14.3397
Total 38.7075.902914916748+537820+3.6%

3.3. Insider Transactions

Insiders are holding 4.196% of the shares of Pulmonx Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-22Geoffrey Beran RoseSELL11849.36
2024-03-01David Aaron LehmanSELL43519.06
2024-03-01Geoffrey Beran RoseSELL30979.06
2024-03-01Glendon E French IiiSELL69549.06
2024-03-01John MckuneSELL10789.06
2024-02-22Geoffrey Beran RoseSELL118414.2
2024-02-15Glendon E French IiiSELL2000014.6
2024-01-22Geoffrey Beran RoseSELL118413.13
2024-01-18Glendon E French IiiSELL1000012.77
2023-12-22Geoffrey Beran RoseSELL118412.75
2023-12-21Glendon E French IiiSELL1000012.42
2023-12-01John MckuneSELL94210.34
2023-12-01Glendon E French IiiSELL667610.34
2023-12-01Geoffrey Beran RoseSELL286810.34
2023-12-01David Aaron LehmanSELL380910.34
2023-11-22Geoffrey Beran RoseSELL118410.6
2023-10-23Geoffrey Beran RoseSELL11848.35
2023-09-22Geoffrey Beran RoseSELL118410.51
2023-09-01David Aaron LehmanSELL377210.01
2023-09-01Derrick SungSELL421910

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pulmonx Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.193-0.232+20%-0.255+32%0.162-219%0.128-251%
Book Value Per Share--3.0703.386-9%4.358-30%2.316+33%1.834+67%
Current Ratio--6.4918.181-21%9.638-33%8.303-22%7.766-16%
Debt To Asset Ratio--0.3390.313+8%0.192+76%0.963-65%1.125-70%
Debt To Equity Ratio--0.5120.456+12%0.238+115%10.714-95%8.731-94%
Dividend Per Share---0.130-100%-0%0.027-100%0.022-100%
Eps---0.360-0.395+10%-0.382+6%-0.296-18%-0.241-33%
Free Cash Flow Per Share---0.224-0.249+11%-0.301+34%-0.241+7%-0.196-13%
Free Cash Flow To Equity Per Share---0.224-0.110-51%-0.285+27%0.119-289%0.094-337%
Gross Profit Margin--1.0001.0000%1.107-10%0.988+1%0.990+1%
Intrinsic Value_10Y_max---10.700--------
Intrinsic Value_10Y_min---9.291--------
Intrinsic Value_1Y_max---1.118--------
Intrinsic Value_1Y_min---1.098--------
Intrinsic Value_3Y_max---3.323--------
Intrinsic Value_3Y_min---3.173--------
Intrinsic Value_5Y_max---5.487--------
Intrinsic Value_5Y_min---5.096--------
Market Cap289030500.000-70%491351850.000456379159.500+8%622571697.000-21%687426084.632-29%544212317.000-10%
Net Profit Margin---0.720-0.899+25%-1.116+55%-0.969+34%-4.031+459%
Operating Margin---0.722-0.916+27%-1.116+55%-0.939+30%-3.715+415%
Operating Ratio--1.7221.916-10%2.116-19%1.904-10%4.521-62%
Pb Ratio2.443-70%4.1533.521+18%3.645+14%3.679+13%2.912+43%
Pe Ratio-5.203+41%-8.845-7.529-15%-10.450+18%-14.325+62%-11.341+28%
Price Per Share7.500-70%12.75011.843+8%16.155-21%17.838-29%14.122-10%
Price To Free Cash Flow Ratio-8.354+41%-14.203-12.373-13%-13.121-8%-16.990+20%-13.450-5%
Price To Total Gains Ratio-38.911+41%-66.149-30.464-54%-62.801-5%-86.958+31%-86.958+31%
Quick Ratio--7.0968.835-20%10.601-33%8.485-16%6.717+6%
Return On Assets---0.078-0.080+3%-0.070-9%-0.223+188%-0.331+327%
Return On Equity---0.117-0.117-1%-0.087-26%-0.569+385%-0.617+426%
Total Gains Per Share---0.193-0.102-47%-0.255+32%0.189-202%0.150-229%
Usd Book Value--118315000.000130486000.000-9%167954000.000-30%89237876.211+33%70686545.125+67%
Usd Book Value Change Per Share---0.193-0.232+20%-0.255+32%0.162-219%0.128-251%
Usd Book Value Per Share--3.0703.386-9%4.358-30%2.316+33%1.834+67%
Usd Dividend Per Share---0.130-100%-0%0.027-100%0.022-100%
Usd Eps---0.360-0.395+10%-0.382+6%-0.296-18%-0.241-33%
Usd Free Cash Flow---8649000.000-9604250.000+11%-11600250.000+34%-9274973.684+7%-7561541.875-13%
Usd Free Cash Flow Per Share---0.224-0.249+11%-0.301+34%-0.241+7%-0.196-13%
Usd Free Cash Flow To Equity Per Share---0.224-0.110-51%-0.285+27%0.119-289%0.094-337%
Usd Market Cap289030500.000-70%491351850.000456379159.500+8%622571697.000-21%687426084.632-29%544212317.000-10%
Usd Price Per Share7.500-70%12.75011.843+8%16.155-21%17.838-29%14.122-10%
Usd Profit---13888000.000-15210750.000+10%-14635000.000+5%-10959315.789-21%-8928567.083-36%
Usd Revenue--19278000.00017168750.000+12%13415500.000+44%11733526.316+64%9289408.333+108%
Usd Total Gains Per Share---0.193-0.102-47%-0.255+32%0.189-202%0.150-229%
 EOD+3 -5MRQTTM+18 -17YOY+18 -165Y+17 -1910Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Pulmonx Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.203
Price to Book Ratio (EOD)Between0-12.443
Net Profit Margin (MRQ)Greater than0-0.720
Operating Margin (MRQ)Greater than0-0.722
Quick Ratio (MRQ)Greater than17.096
Current Ratio (MRQ)Greater than16.491
Debt to Asset Ratio (MRQ)Less than10.339
Debt to Equity Ratio (MRQ)Less than10.512
Return on Equity (MRQ)Greater than0.15-0.117
Return on Assets (MRQ)Greater than0.05-0.078
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Pulmonx Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.926
Ma 20Greater thanMa 508.401
Ma 50Greater thanMa 10010.006
Ma 100Greater thanMa 20011.278
OpenGreater thanClose7.430
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets178,951
Total Liabilities60,636
Total Stockholder Equity118,315
 As reported
Total Liabilities 60,636
Total Stockholder Equity+ 118,315
Total Assets = 178,951

Assets

Total Assets178,951
Total Current Assets150,322
Long-term Assets28,629
Total Current Assets
Cash And Cash Equivalents 83,784
Short-term Investments 33,555
Net Receivables 13,424
Inventory 16,743
Other Current Assets 2,816
Total Current Assets  (as reported)150,322
Total Current Assets  (calculated)150,322
+/- 0
Long-term Assets
Property Plant Equipment 7,434
Goodwill 2,333
Long Term Investments 14,390
Intangible Assets 31
Long-term Assets Other 3,271
Long-term Assets  (as reported)28,629
Long-term Assets  (calculated)27,459
+/- 1,170

Liabilities & Shareholders' Equity

Total Current Liabilities23,157
Long-term Liabilities37,479
Total Stockholder Equity118,315
Total Current Liabilities
Short-term Debt 5,229
Short Long Term Debt 2,155
Accounts payable 1,497
Other Current Liabilities 16,327
Total Current Liabilities  (as reported)23,157
Total Current Liabilities  (calculated)25,208
+/- 2,051
Long-term Liabilities
Long term Debt 35,089
Capital Lease Obligations 4,180
Long-term Liabilities  (as reported)37,479
Long-term Liabilities  (calculated)39,269
+/- 1,790
Total Stockholder Equity
Common Stock39
Retained Earnings -411,161
Accumulated Other Comprehensive Income 2,640
Other Stockholders Equity 526,797
Total Stockholder Equity (as reported)118,315
Total Stockholder Equity (calculated)118,315
+/-0
Other
Capital Stock39
Cash and Short Term Investments 117,339
Common Stock Shares Outstanding 38,377
Current Deferred Revenue104
Liabilities and Stockholders Equity 178,951
Net Debt -42,360
Net Invested Capital 155,559
Net Working Capital 127,265
Property Plant and Equipment Gross 12,289
Short Long Term Debt Total 41,424



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
578
2,124
3,678
2,693
1,465
0
0
53,533
0
66,721
71,244
263,708
255,270
248,940
246,818
235,173
222,849
212,729
202,203
193,676
201,272
193,113
185,016
178,951
178,951185,016193,113201,272193,676202,203212,729222,849235,173246,818248,940255,270263,70871,24466,721053,533001,4652,6933,6782,124578
   > Total Current Assets 
38
1,566
3,170
2,135
972
0
0
41,071
0
55,824
55,622
249,989
239,344
233,084
227,644
208,002
200,725
192,781
187,670
168,953
181,298
164,428
147,364
150,322
150,322147,364164,428181,298168,953187,670192,781200,725208,002227,644233,084239,344249,98955,62255,824041,071009722,1353,1701,56638
       Cash And Cash Equivalents 
29
1,549
2,955
1,783
637
0
0
14,767
0
43,347
39,806
231,561
209,283
198,703
188,075
148,480
129,168
121,947
112,402
101,736
110,407
101,581
94,945
83,784
83,78494,945101,581110,407101,736112,402121,947129,168148,480188,075198,703209,283231,56139,80643,347014,767006371,7832,9551,54929
       Short-term Investments 
0
0
0
0
0
0
0
13,580
0
0
0
0
9,784
10,774
11,774
31,561
40,914
40,139
44,497
39,402
42,429
33,571
21,537
33,555
33,55521,53733,57142,42939,40244,49740,13940,91431,56111,77410,7749,784000013,5800000000
       Net Receivables 
0
0
0
0
0
0
0
5,898
0
3,150
5,260
4,228
5,119
6,884
6,919
6,562
6,810
7,521
7,221
8,677
8,171
8,941
10,091
13,424
13,42410,0918,9418,1718,6777,2217,5216,8106,5626,9196,8845,1194,2285,2603,15005,8980000000
       Other Current Assets 
0
17
215
352
335
0
0
766
0
153
1,037
3,228
3,011
3,091
5,660
4,883
702
3,937
183
4,343
4,472
4,233
4,424
2,816
2,8164,4244,2334,4724,3431833,9377024,8835,6603,0913,0113,2281,037153076600335352215170
   > Long-term Assets 
0
0
0
0
0
0
0
12,462
0
10,897
15,622
13,719
15,926
15,856
19,174
27,171
22,124
19,948
14,533
24,723
19,974
28,685
37,652
28,629
28,62937,65228,68519,97424,72314,53319,94822,12427,17119,17415,85615,92613,71915,62210,897012,4620000000
       Property Plant Equipment 
83
395
348
399
337
0
0
7,463
0
7,691
10,653
10,450
10,203
10,600
13,177
12,889
12,436
11,919
11,328
10,500
9,642
8,924
8,126
7,434
7,4348,1268,9249,64210,50011,32811,91912,43612,88913,17710,60010,20310,45010,6537,69107,4630033739934839583
       Goodwill 
0
0
0
0
0
0
0
2,333
0
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,33302,3330000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
2,498
2,024
2,798
10,941
6,379
4,684
0
5,924
2,637
12,454
23,271
14,390
14,39023,27112,4542,6375,92404,6846,37910,9412,7982,0242,498000000000000
       Intangible Assets 
166
163
161
159
156
0
0
524
0
462
431
400
370
339
308
277
247
216
185
154
123
92
62
31
316292123154185216247277308339370400431462052400156159161163166
       Long-term Assets Other 
0
0
0
0
0
0
0
2,142
0
411
2,205
536
522
560
558
731
729
796
687
5,404
5,239
4,882
3,860
3,271
3,2713,8604,8825,2395,4046877967297315585605225362,20541102,1420000000
> Total Liabilities 
3,414
1,708
1,464
1,467
1,528
0
0
240,911
0
31,926
278,133
37,574
38,655
39,020
43,990
41,934
40,704
40,547
38,721
39,669
57,338
59,161
59,273
60,636
60,63659,27359,16157,33839,66938,72140,54740,70441,93443,99039,02038,65537,574278,13331,9260240,911001,5281,4671,4641,7083,414
   > Total Current Liabilities 
760
312
257
260
321
0
0
14,161
0
8,555
15,174
12,526
14,023
16,326
22,217
17,550
17,715
20,446
21,686
18,492
17,079
19,521
20,485
23,157
23,15720,48519,52117,07918,49221,68620,44617,71517,55022,21716,32614,02312,52615,1748,555014,16100321260257312760
       Short-term Debt 
2,790
1,396
102
1,207
0
0
0
446
0
1,311
1,927
2,238
2,246
3,581
5,252
2,292
3,765
5,982
8,188
3,319
3,390
3,446
3,527
5,229
5,2293,5273,4463,3903,3198,1885,9823,7652,2925,2523,5812,2462,2381,9271,31104460001,2071021,3962,790
       Short Long Term Debt 
2,790
1,396
102
1,207
0
0
0
0
0
0
0
0
472
1,889
3,306
91
798
2,921
5,043
90
91
93
91
2,155
2,155919391905,0432,921798913,3061,889472000000001,2071021,3962,790
       Accounts payable 
358
312
156
260
321
0
0
2,681
0
999
2,297
1,472
1,826
2,156
4,434
1,582
2,803
2,599
2,648
1,758
2,890
2,377
3,189
1,497
1,4973,1892,3772,8901,7582,6482,5992,8031,5824,4342,1561,8261,4722,29799902,68100321260156312358
       Other Current Liabilities 
0
0
0
0
0
0
0
10,861
0
6,195
10,858
8,745
9,876
10,504
12,374
13,513
11,015
11,734
10,744
13,295
10,692
13,603
13,684
16,327
16,32713,68413,60310,69213,29510,74411,73411,01513,51312,37410,5049,8768,74510,8586,195010,8610000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
226,750
0
23,371
262,959
25,048
24,632
22,694
21,773
24,384
22,989
20,101
17,035
21,177
40,259
39,640
38,788
37,479
37,47938,78839,64040,25921,17717,03520,10122,98924,38421,77322,69424,63225,048262,95923,3710226,7500000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
564
532
544
716
634
16,629
14,460
12,340
0
37,173
37,147
0
0
0037,14737,173012,34014,46016,62963471654453256400000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
3,364
54
62
71
71
70
37
232
226
51
94
71
0
0
0
0007194512262323770717162543,364000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,680
62
71
71
70
37
53
0
0
94
0
0
0
0
000094005337707171621,6800000000000
> Total Stockholder Equity
-2,836
416
2,214
1,227
-63
0
0
-187,378
0
34,795
-206,889
226,134
216,615
209,920
202,828
193,239
182,145
172,182
163,482
154,007
143,934
133,952
125,743
118,315
118,315125,743133,952143,934154,007163,482172,182182,145193,239202,828209,920216,615226,134-206,88934,7950-187,37800-631,2272,214416-2,836
   Common Stock
24
28
31
4
4
0
0
19
0
22
4
36
36
36
37
37
37
37
37
38
38
38
38
39
393838383837373737373636364220190044312824
   Retained Earnings Total Equity00-382,373-366,178-350,318-336,035-321,863-307,223-291,395-278,389-267,156-254,779-242,73400000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
1,373
0
1,615
1,648
1,685
1,410
1,479
1,544
1,712
1,443
1,357
1,397
1,575
1,820
1,956
1,944
2,640
2,6401,9441,9561,8201,5751,3971,3571,4431,7121,5441,4791,4101,6851,6481,61501,3730000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
467,147
469,948
475,561
479,636
482,885
487,888
492,651
498,083
502,712
508,254
514,331
0
0
00514,331508,254502,712498,083492,651487,888482,885479,636475,561469,948467,14700000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
21,733
0
259,435
24,896
467,147
469,948
475,561
479,636
482,885
487,888
492,651
498,083
502,712
508,254
514,331
521,034
526,797
526,797521,034514,331508,254502,712498,083492,651487,888482,885479,636475,561469,948467,14724,896259,435021,7330000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue68,675
Cost of Revenue-18,323
Gross Profit50,35250,352
 
Operating Income (+$)
Gross Profit50,352
Operating Expense-112,287
Operating Income-61,935-61,935
 
Operating Expense (+$)
Research Development18,080
Selling General Administrative92,092
Selling And Marketing Expenses0
Operating Expense112,287110,172
 
Net Interest Income (+$)
Interest Income4,775
Interest Expense-3,232
Other Finance Cost-546
Net Interest Income2,089
 
Pretax Income (+$)
Operating Income-61,935
Net Interest Income2,089
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-60,272-63,598
EBIT - interestExpense = -65,167
-60,272
-57,611
Interest Expense3,232
Earnings Before Interest and Taxes (EBIT)-61,935-57,040
Earnings Before Interest and Taxes (EBITDA)-59,987
 
After tax Income (+$)
Income Before Tax-60,272
Tax Provision-569
Net Income From Continuing Ops-61,238-60,841
Net Income-60,843
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses130,610
Total Other Income/Expenses Net1,663-2,089
 

Technical Analysis of Pulmonx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pulmonx. The general trend of Pulmonx is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pulmonx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pulmonx Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.75 < 8.62 < 9.71.

The bearish price targets are: 7.23 > 6.78 > 6.55.

Tweet this
Pulmonx Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pulmonx Corp. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pulmonx Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pulmonx Corp. The current macd is -0.62903943.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pulmonx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pulmonx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pulmonx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pulmonx Corp Daily Moving Average Convergence/Divergence (MACD) ChartPulmonx Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pulmonx Corp. The current adx is 41.29.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pulmonx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Pulmonx Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pulmonx Corp. The current sar is 8.26159372.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pulmonx Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pulmonx Corp. The current rsi is 30.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Pulmonx Corp Daily Relative Strength Index (RSI) ChartPulmonx Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pulmonx Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pulmonx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Pulmonx Corp Daily Stochastic Oscillator ChartPulmonx Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pulmonx Corp. The current cci is -118.85859398.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pulmonx Corp Daily Commodity Channel Index (CCI) ChartPulmonx Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pulmonx Corp. The current cmo is -40.63725038.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pulmonx Corp Daily Chande Momentum Oscillator (CMO) ChartPulmonx Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pulmonx Corp. The current willr is -86.05769231.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pulmonx Corp Daily Williams %R ChartPulmonx Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pulmonx Corp.

Pulmonx Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pulmonx Corp. The current atr is 0.42145272.

Pulmonx Corp Daily Average True Range (ATR) ChartPulmonx Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pulmonx Corp. The current obv is 5,437,828.

Pulmonx Corp Daily On-Balance Volume (OBV) ChartPulmonx Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pulmonx Corp. The current mfi is 24.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pulmonx Corp Daily Money Flow Index (MFI) ChartPulmonx Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pulmonx Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Pulmonx Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pulmonx Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.926
Ma 20Greater thanMa 508.401
Ma 50Greater thanMa 10010.006
Ma 100Greater thanMa 20011.278
OpenGreater thanClose7.430
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pulmonx with someone you think should read this too:
  • Are you bullish or bearish on Pulmonx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pulmonx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pulmonx Corp

I send you an email if I find something interesting about Pulmonx Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Pulmonx Corp.

Receive notifications about Pulmonx Corp in your mailbox!